Caris Life Sciences Launches IPO Roadshow

Jun 9, 2025
Caris Life Sciences has initiated the roadshow for its initial public offering, aiming to list on Nasdaq under the ticker 'CAI'.
Caris Life Sciences Launches IPO Roadshow

Caris Life Sciences has launched the roadshow for its proposed initial public offering (IPO) of common stock, announced in a press release. The company plans to offer 23,529,412 shares, with an additional option for underwriters to purchase up to 3,529,411 more shares. The IPO price is expected to range between $16.00 and $18.00 per share.

Caris has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission and intends to list its common stock on the Nasdaq Global Select Market under the ticker symbol "CAI." BofA Securities, J.P. Morgan, and Goldman Sachs & Co. LLC are among the lead book-running managers for the offering, with Citigroup also participating as a book-running manager.

The IPO will be conducted through a prospectus, and the registration statement has been filed but is not yet effective. This marks a significant step for Caris, a company known for its advancements in precision medicine and AI-driven molecular profiling.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

AI Funding News AI Brief AI Brief (X)
Free newsletter

AI Funding Brief

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.